Odonate Therapeutics LLC-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Odonate Therapeutics LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011897
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Odonate Therapeutics LLC (Odonate) is a company that develops medicines for the treatment of cancer. It develops best in class medicines that enhance and extend the lives of patients suffering from cancer. Odonate’s lead product candidate, tesetaxel, is a novel orally administered taxane used for the treatment of various cancers. Tesetaxel demonstrated the retention of activity against taxane-resistant tumors in both in vitro and in vivo studies. The company is conducting a multinational, multicenter, Phase III clinical trial of tesetaxel in patients with locally advanced or metastatic breast cancer (MBC). Odonate is headquartered in San Diego, California, the US.

Odonate Therapeutics LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Odonate Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Odonate Therapeutics LLC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Odonate Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Odonate Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Odonate Therapeutics LLC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Odonate Therapeutics LLC, Pharmaceuticals & Healthcare, Deal Details 10
Licensing Agreements 10
Odonate Therapeutics Enters into Licensing Agreement with Daiichi Sankyo 10
Equity Offering 11
Odonate Therapeutics Raises USD150 Million in IPO 11
Odonate Therapeutics Raises USD74 million in Private Placement of Units 12
Odonate Therapeutics Raised USD10 Million in Private Placement of Units 13
Odonate Therapeutics Raises USD5 Million in Private Placement of Units 14
Odonate Therapeutics LLC – Key Competitors 15
Odonate Therapeutics LLC – Key Employees 16
Odonate Therapeutics LLC – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Corporate Communications 18
Oct 03, 2017: Susan G. Komen Launches Its First Crowdfunding Initiative to Support Metastatic Breast Cancer Research 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Odonate Therapeutics LLC, Pharmaceuticals & Healthcare, Key Facts 2
Odonate Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Odonate Therapeutics LLC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Odonate Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Odonate Therapeutics LLC, Deals By Therapy Area, 2011 to YTD 2017 8
Odonate Therapeutics LLC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Odonate Therapeutics Enters into Licensing Agreement with Daiichi Sankyo 10
Odonate Therapeutics Raises USD150 Million in IPO 11
Odonate Therapeutics Raises USD74 million in Private Placement of Units 12
Odonate Therapeutics Raised USD10 Million in Private Placement of Units 13
Odonate Therapeutics Raises USD5 Million in Private Placement of Units 14
Odonate Therapeutics LLC, Key Competitors 15
Odonate Therapeutics LLC, Key Employees 16

★海外企業調査レポート[Odonate Therapeutics LLC-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • OrthoPediatrics Corp (KIDS):医療機器:M&Aディール及び事業提携情報
    Summary OrthoPediatrics Corp (OrthoPediatrics) is a medical device company that designs, develops and distributes implants and instruments. The company offers trauma and deformity, spine, sports medicine, and clinical education products. It provides cannulated screws, spine system, ACL reconstructio …
  • Stock Spirits Group PLC:企業の戦略・SWOT・財務分析
    Stock Spirits Group PLC - Strategy, SWOT and Corporate Finance Report Summary Stock Spirits Group PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Modern Water plc (MWG):企業の財務・戦略的SWOT分析
    Summary Modern Water Plc (Modern Water) is a clean technology company that develops and supplies water monitoring systems. The company owns, installs and operates membrane technologies, develops and supplies systems for water monitoring. Its membrane process division utilizes forward osmosis technol …
  • NovImmune SA-製薬・医療分野:企業M&A・提携分析
    Summary NovImmune SA (NovImmune) is a biopharmaceutical company that discovers and develops antibody-based drugs for the treatment of inflammatory diseases, immune-related disorders and cancer. The company develops pipeline products using its proprietary mAb generating platform, DiversityTrap and ka …
  • Allscripts Healthcare Solutions Inc (MDRX):医療機器:M&Aディール及び事業提携情報
    Summary Allscripts Healthcare Solutions Inc (Allscripts), formerly Allscripts-Misys Healthcare Solutions, Inc., is a provider of healthcare information technology solutions. The company’s major solutions include Electronic Health Records (EHR), Financial Management Solutions, Population Health Manag …
  • Daiho Corporation
    Daiho Corporation - Strategy, SWOT and Corporate Finance Report Summary Daiho Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Hanesbrands Inc (HBI):企業の財務・戦略的SWOT分析
    Hanesbrands Inc (HBI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Sol-Gel Technologies Ltd (SLGL):製薬・医療:M&Aディール及び事業提携情報
    Summary Sol-Gel Technologies Ltd (Sol-Gel) is a clinical-stage dermatology company that identifies, develops and commercializes branded and generic topical dermatological drug products for the treatment of skin diseases. The company’s pipeline products include vered, twin and sirs-t drug candidates. …
  • ShaMaran Petroleum Corp (SNM):企業の財務・戦略的SWOT分析
    Summary ShaMaran Petroleum Corp (ShaMaran Petroleum), formerly Bayou Bend Petroleum Ltd is an independent oil and gas exploration and development company. The corporation explores, produces, and develops oil and gas assets. It holds interests and operates Atrush petroleum property located in Kurdist …
  • Futura Medical Plc (FUM):製薬・医療:M&Aディール及び事業提携情報
    Summary Futura Medical Plc (Futura Medical) is a pharmaceutical company that focuses on research and development of novel products for various therapeutic areas, including sexual health and pain relief management. The company focuses on developing pharmaceutical products based on its transdermal dru …
  • Avery Dennison Corporation:企業の戦略・SWOT・財務情報
    Avery Dennison Corporation - Strategy, SWOT and Corporate Finance Report Summary Avery Dennison Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Bausch Health Companies Inc (VRX):医療機器:M&Aディール及び事業提携情報
    Summary Bausch Health Companies Inc(Bausch Health) formerly known as Valeant Pharmaceuticals International Inc, develops, manufactures and markets several branded, over-the-counter (OTC) and generic drugs. The company also offers medical devices such as medical contact lenses, intraocular lenses, op …
  • University of Utah-製薬・医療分野:企業M&A・提携分析
    Summary University of Utah (University of Utah) is a research university that offers various undergraduate and postgraduate programs. The university offers educational programs in various fields such as architecture and planning, engineering, fine arts, health, humanities, law, medicine, business, d …
  • Pictet & Cie Group SCA:企業の戦略・SWOT・財務情報
    Pictet & Cie Group SCA - Strategy, SWOT and Corporate Finance Report Summary Pictet & Cie Group SCA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Richard Wolf GmbH:企業の戦略的SWOT分析
    Richard Wolf GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • AyoxxA Biosystems GmbH:医療機器:M&Aディール及び事業提携情報
    Summary AyoxxA Biosystems GmbH (AyoxxA) is a life science tools company that provides protein analysis solutions. The company offers multiple detection kits, cytokine detection kits, human inflammation kits, mouse inflammation kits, and human opthalmology kits. Its services include complete testing …
  • Torrent Power Limited:企業の戦略・SWOT・財務情報
    Torrent Power Limited - Strategy, SWOT and Corporate Finance Report Summary Torrent Power Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Fortum Corp (FORTUM):石油・ガス:M&Aディール及び事業提携情報
    Summary Fortum Corp (Fortum) is a clean energy company, which generates, distributes and sells heat and electricity. The company undertakes operation and maintenance of power plants; and offers energy-related services. Fortum's operational assets include hydropower plants, condensing power plants, w …
  • Wartsila Corporation (WRT1V):電力:M&Aディール及び事業提携情報
    Summary Wartsila Corporation (Wartsila) is a mechanical or industrial engineering company. It offers smart technologies and complete lifecycle solutions. Through sustainable innovation, total efficiency, and data analytics, the company harnesses the environmental and economic performance of the vess …
  • Shutterfly Inc:企業の戦略的SWOT分析
    Shutterfly Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆